EPINEX DIABETES BLOG

According to the Centre for Disease Control and Prevention, CDC report 2017; 30.3 million Americans – 9.4 percent of the U.S. population...

Asad Zaidi, founder and CEO of Epinex Diagnostics Inc., presented at the Plug and Play Tech Center for the event called Health Tech...

The 2018 LIGHT Forum, Leaders in Global Healthcare and Technology, is happening on May 8-9th at Stanford University, in attendance will...

Stress hyperglycemia, or “stress diabetes,” is a condition that causes temporarily elevated blood glucose during recovery after a heart...

A recent review article written by Epinex’s staff and published by Springer-Nature Journal “Inflammation Research’ 2017, highlights the...

Cardiovascular autonomic neuropathy (CAN) is one of the most overlooked of the serious complications of diabetes. CAN causes damage to...

Figure 1 A Review of Glycated Albumin appears first on Google search and has reached 100 citations Epinex Diagnostics, Inc. reaches a new...

Epinex attended the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, which took place July 30 through August 3 2017 at the San...

The American Association for Clinical Chemistry (AACC) and the American Diabetes Association (ADA) have recognized the need to look...

Diabetes is rampant in the United States and places an increasing burden on the U.S. healthcare system. In California, 9 percent of...